Status:
TERMINATED
Evaluation of Oxygen Therapy Delivery Systems in Hypoxemic Acute Respiratory Failure
Lead Sponsor:
Nantes University Hospital
Conditions:
Acute Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of this study is to evaluate the efficiency of the oxygen therapy delivery system Optiflow® compared to 2 others standard oxygen therapy delivery systems (Ospal®, non invasive venti...
Eligibility Criteria
Inclusion
- Patient hospitalized in the intensive care unit of Nantes University Hospital
- Signed informed consent
- Patient with not hypercapnic acute hypoxemic respiratory failure
- Immunocompetent and immunodeficient patient
Exclusion
- Age \< 18 years
- Pregnancy
- Contra-indication to non invasive ventilation
- Allergy to xylocaine
- Coagulation troubles
- Tracheotomized patient
- Urgent indication to intubation
- Hypercapnic acute respiratory failure
- Acute pulmonary edema
- Face or nose malformation
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01243918
Start Date
November 1 2010
End Date
June 1 2013
Last Update
October 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France